vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Plymouth Industrial REIT, Inc. (PLYM). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $51.2M, roughly 1.6× Plymouth Industrial REIT, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs -106.3%, a 113.1% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -1.4%).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.
BLLN vs PLYM — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $51.2M |
| Net Profit | $5.7M | $-54.4M |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | -102.5% |
| Net Margin | 6.8% | -106.3% |
| Revenue YoY | 117.4% | -1.4% |
| Net Profit YoY | 138.3% | -248.5% |
| EPS (diluted) | $0.10 | $-1.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $83.5M | $51.2M | ||
| Q2 25 | — | $47.2M | ||
| Q1 25 | — | $45.6M | ||
| Q4 24 | — | $47.6M | ||
| Q3 24 | $38.4M | $51.9M | ||
| Q2 24 | — | $48.7M | ||
| Q1 24 | — | $50.2M | ||
| Q4 23 | — | $50.8M |
| Q3 25 | $5.7M | $-54.4M | ||
| Q2 25 | — | $-6.1M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $147.4M | ||
| Q3 24 | $-14.9M | $-15.6M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $6.2M | ||
| Q4 23 | — | $9.3M |
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 11.5% | -102.5% | ||
| Q2 25 | — | -10.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -32.9% | -29.6% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 6.8% | -106.3% | ||
| Q2 25 | — | -12.9% | ||
| Q1 25 | — | 12.8% | ||
| Q4 24 | — | 309.9% | ||
| Q3 24 | -38.8% | -30.1% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 12.4% | ||
| Q4 23 | — | 18.3% |
| Q3 25 | $0.10 | $-1.23 | ||
| Q2 25 | — | $-0.14 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | — | $3.24 | ||
| Q3 24 | $-1.47 | $-0.35 | ||
| Q2 24 | — | $0.03 | ||
| Q1 24 | — | $0.14 | ||
| Q4 23 | — | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | — |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $470.1M |
| Total Assets | $327.5M | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $646.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $873.4M |
| Q3 25 | $-239.5M | $470.1M | ||
| Q2 25 | — | $539.6M | ||
| Q1 25 | — | $571.0M | ||
| Q4 24 | — | $579.5M | ||
| Q3 24 | $-242.9M | $436.5M | ||
| Q2 24 | — | $475.2M | ||
| Q1 24 | — | $484.6M | ||
| Q4 23 | — | $483.0M |
| Q3 25 | $327.5M | $1.6B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B | ||
| Q4 23 | — | $1.4B |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $20.0M |
| Free Cash FlowOCF − Capex | $6.5M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $13.8M | $20.0M | ||
| Q2 25 | — | $23.4M | ||
| Q1 25 | — | $15.6M | ||
| Q4 24 | — | $96.1M | ||
| Q3 24 | — | $17.6M | ||
| Q2 24 | — | $19.9M | ||
| Q1 24 | — | $16.6M | ||
| Q4 23 | — | $18.6M |
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 7.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 8.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.67× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 15.12× | ||
| Q1 24 | — | 2.67× | ||
| Q4 23 | — | 2.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
PLYM
Segment breakdown not available.
